Sienna Biopharmaceuticals, Inc.

SNNAQ

SNNAQSienna Biopharmaceuticals, Inc. US flag

Other OTC

0.00

USD

- -

3,091.00Market Cap

Income Statement (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y
Sales/Revenue/Turnover	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -
- Operating Expenses	11	21	49	76
+ Selling, General & Admin	9	10	18	25
+ Research & Development	2	11	30	52
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-11	-21	-49	-76
- Non-Operating (Income) Loss	- -	- -	2	-3
+ Interest Expense, Net	1	1	- -	- -
+ Interest Expense	1	1	- -	- -
- Interest Income	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	- -	2	-3
Pretax Income	-11	-21	-51	-73
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-11	-21	-51	-73
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-11	-21	-51	-73
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-11	-21	-51	-73
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-11	-21	-51	-73
EBIT	-11	-21	-49	-76
EBITDA	-11	-21	-48	-76
EBITDA Margin (%)	- -	- -	- -	- -
EBITA	-11	-21	-49	-76
Gross Margin (%)	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -
Basic Weighted Avg Shares	11	11	10	20
Basic EPS, GAAP	-0.99	-1.86	-5.19	-3.59
Basic EPS from Cont Ops	-0.99	-1.86	-5.19	-3.59
Diluted Weighted Avg Shares	11	11	10	20
Diluted EPS, GAAP	-0.99	-1.86	-5.19	-3.59
Diluted EPS from Cont Ops	-0.99	-1.86	-5.19	-3.59

Balance Sheet (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y
Total Current Assets	6	11	77	50
+ Cash, Cash Equivalents & STI	5	9	74	49
+ Cash & Cash Equivalents	5	9	74	49
+ ST Investments	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	1	1	3	2
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	- -	52	60	57
+ Property, Plant & Equip, Net	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	1	1
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	52	59	57
+ Total Intangible Assets	- -	52	59	57
+ Goodwill	- -	10	11	11
+ Other Intangible Assets	- -	42	48	46
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -
Total Assets	6	62	137	107
+ Payables & Accruals	1	5	8	11
+ Accounts Payable	1	2	2	3
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	- -	3	6	8
+ ST Debt	- -	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -
+ Other ST Liabilities	- -	5	- -	14
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	- -	5	- -	14
Total Current Liabilities	1	10	8	24
+ LT Debt	- -	- -	- -	30
+ LT Borrowings	- -	- -	- -	30
+ LT Finance Leases	- -	- -	- -	- -
+ Other LT Liabilities	1	30	37	26
+ Accrued Liabilities	- -	9	11	11
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	1	21	26	16
Total Noncurrent Liabilities	1	30	37	56
Total Liabilities	2	40	46	81
+ Preferred Equity and Hybrid Capital	20	60	- -	- -
+ Share Capital & APIC	-2	-2	172	183
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	-2	-2	172	183
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-14	-35	-86	-159
+ Other Equity	- -	- -	5	3
Equity Before Minority Interest	4	22	91	27
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	4	22	91	27
Total Liabilities & Equity	6	62	137	107
Shares Outstanding	20	20	20	21
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -
Net Debt	-5	-9	-74	-18
Net Debt to Equity	-122.49	-41.1	-81.65	-69.23
Tangible Common Equity Ratio	-283.26	-822.49	41.31	-59.15
Current Ratio	5.59	1.06	9.39	2.07
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y
+ Net Income	-11	-21	-51	-73
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	1	1	8	8
+ Stock-Based Compensation	- -	- -	2	5
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	1	1	6	4
+ Chg in Non-Cash Work Cap	- -	3	2	3
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-1	- -	-1	1
+ Inc (Dec) in Accts Payable	1	3	3	2
+ Inc (Dec) in Other	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-10	-18	-41	-62
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	-3	1	67	6
+ Increase in Capital Stock	- -	1	67	6
+ Decrease in Capital Stock	-3	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	-7	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	-7	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	- -	-7	- -	- -
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	-1	- -	4	30
+ Cash From Debt	13	- -	4	30
+ Repayments of Debt	-14	- -	- -	- -
+ Other Financing Activities	19	28	36	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	15	29	107	36
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	5	4	66	-26
EBITDA	-11	-21	-48	-76
EBITDA Margin (%)	- -	- -	- -	- -
Free Cash Flow	-10	-18	-41	-62
Net Cash Paid for Acquisitions	- -	7	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	21	-97	-32
Free Cash Flow per Basic Share	-0.88	-1.57	-4.24	-3.02
Price/Free Cash Flow	- -	- -	-4.34	-0.77
Cash Flow to Net Income	0.88	0.83	0.81	0.84
Capital Expenditures	- -	- -	- -	- -